Value through Innovation27 July 2016

Clinical Study Results

  • INFLAMMIDE ® - Asthma
    Clinical Study Number 1047.16
    Study Indication Asthma
    Product INFLAMMIDE ®
    Generic Name Budesonide
    Lab Code
    Clinical Phase IIIa
    Study Title

    A Randomised Double-Blind, Double-Dummy, Parallel Group Design.Twelve-week, Efficacy and Safety Study Comparing Respimat ® Budesonide (100 and 200 mcg, 2 puffs bid) with Turbohaler® Budesonide (200 mcg, 2 puffs bid) in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy.

    Study Document Trial synopsis 1047.16 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.